Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction.

Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

J Clin Med. 2020 Jan 15;9(1). pii: E225. doi: 10.3390/jcm9010225.

2.

Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G.

Urol Oncol. 2020 Jan 13. pii: S1078-1439(19)30505-8. doi: 10.1016/j.urolonc.2019.12.018. [Epub ahead of print]

PMID:
31948932
3.

Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

Urology. 2019 Dec 30. pii: S0090-4295(19)31124-0. doi: 10.1016/j.urology.2019.10.039. [Epub ahead of print]

PMID:
31899229
4.

Living-donor kidney transplantation: comparison of sequential and simultaneous surgical organizations.

Prudhomme T, Benoit T, Mittal S, Roumiguié M, Mesnard B, Broudeur L, Kervella D, Sallusto F, Doumerc N, Binhazzaa M, Iborra F, Soulié M, Blancho G, Kamar N, Thuret R, Karam G, Gamé X, Branchereau J.

Int Urol Nephrol. 2020 Jan 1. doi: 10.1007/s11255-019-02366-0. [Epub ahead of print]

PMID:
31894558
5.

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery.

Ploussard G, Manceau C, Beauval JB, Lesourd M, Almeras C, Gautier JR, Loison G, Salin A, Soulié M, Tollon C, Malavaud B, Roumiguié M.

World J Urol. 2019 Dec 14. doi: 10.1007/s00345-019-03053-6. [Epub ahead of print]

PMID:
31838560
6.

Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional vision.

Prudhomme T, Roumiguié M, Benoit T, Lesourd M, Beauval JB, Doumerc N, Sallusto F, Soulié M, Kamar N, Gamé X.

Clin Transplant. 2019 Dec;33(12):e13745. doi: 10.1111/ctr.13745. Epub 2019 Nov 13.

PMID:
31665808
7.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. [Epub ahead of print]

PMID:
31612251
8.

Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.

Prudhomme T, Marquette T, Péré M, Patard PM, Michiels C, Sallusto F, Rigaud J, Glémain P, Kamar N, Blancho G, Soulié M, Rischmann P, Karam G, Gamé X, Robert G, Branchereau J.

J Endourol. 2020 Feb;34(2):184-191. doi: 10.1089/end.2019.0430. Epub 2019 Nov 8.

PMID:
31588793
9.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27.

PMID:
31246548
10.

Migration of an abdominal mesh into a reconstructed ileal neobladder, diagnosis and management: A case report.

Zgheib J, Roumiguie M, Soulie M, Covin B, Huyghe E.

Urol Case Rep. 2019 Feb 14;24:100846. doi: 10.1016/j.eucr.2019.100846. eCollection 2019 May.

11.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.

Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.

World J Urol. 2019 Jun 13. doi: 10.1007/s00345-019-02848-x. [Epub ahead of print]

PMID:
31197523
12.

Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer.

Schuurhuizen CSEW, Marino P, Braamse AMJ, Buffart LM, Joly F, Fizazi K, Habibian M, Boher JM, Soulie M, Oudard S, Konings IRHM, Verheul HMW, Dekker J, Gravis G.

J Natl Compr Canc Netw. 2018 Dec;16(12):1481-1488. doi: 10.6004/jnccn.2018.7069.

PMID:
30545995
13.

Evaluation of the impact of a clinical pathway on the progression of acute urinary retention.

Gas J, Liaigre-Ramos A, Caubet-Kamar N, Beauval JB, Lesourd M, Prudhomme T, Huyghe E, Soulié M, Charpentier S, Gamé X.

Neurourol Urodyn. 2019 Jan;38(1):387-392. doi: 10.1002/nau.23873. Epub 2018 Nov 12.

PMID:
30418678
14.

Robot-assisted laparoscopic partial nephrectomy with renal artery clamping using an endovascular balloon catheter for an allograft kidney tumor: A new perspective to manage renal vascular control?

Laclergerie F, Delchier MC, Covin B, Sallusto F, Soulie M, Gamé X, Beauval JB, Kamar N, Roumiguié M, Doumerc N.

Am J Transplant. 2019 Apr;19(4):1239-1240. doi: 10.1111/ajt.15151. Epub 2018 Nov 10. No abstract available.

PMID:
30372583
15.

Total intracorporeal robotic renal auto-transplantation: A new minimally invasive approach to preserve the kidney after major ureteral injuries.

Doumerc N, Beauval JB, Roumiguié M, Roulette P, Laclergerie F, Sallusto F, Soulié M, Gamé X, Biscans C.

Int J Surg Case Rep. 2018;49:176-179. doi: 10.1016/j.ijscr.2018.06.017. Epub 2018 Jul 3.

16.

Management of urinary-tract fistulas using reversible balloon nephrostomy: a single-center retrospective analysis of 56 patients.

Gas J, Nouhaud FX, Roumiguié M, Lagarde S, Delchier MC, Huyghe É, Soulié M, Gamé X, Beauval JB.

Int Urogynecol J. 2019 Feb;30(2):287-292. doi: 10.1007/s00192-018-3628-0. Epub 2018 Mar 15.

PMID:
29546601
17.

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.

Gravis G, Boher JM, Chen YH, Liu G, Fizazi K, Carducci MA, Oudard S, Joly F, Jarrard DM, Soulie M, Eisenberger MJ, Habibian M, Dreicer R, Garcia JA, Hussain MHM, Kohli M, Vogelzang NJ, Picus J, DiPaola R, Sweeney C.

Eur Urol. 2018 Jun;73(6):847-855. doi: 10.1016/j.eururo.2018.02.001. Epub 2018 Feb 21.

18.

Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study.

Beauval JB, Peyronnet B, Benoit T, Cabarrou B, Seisen T, Roumiguié M, Pradere B, Khene ZE, Manach Q, Verhoest G, Thoulouzan M, Parra J, Doumerc N, Mathieu R, Vaessen C, Soulié M, Roupret M, Bensalah K.

World J Urol. 2018 Jun;36(6):897-904. doi: 10.1007/s00345-018-2208-8. Epub 2018 Feb 9.

PMID:
29427002
19.

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

Lavaud P, Gravis G, Foulon S, Joly F, Oudard S, Priou F, Latorzeff I, Mourey L, Soulié M, Delva R, Krakowski I, Laguerre B, Théodore C, Ferrero JM, Beuzeboc P, Habibian M, Rolland F, Deplanque G, Pouessel D, Zanetta S, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Tubiana-Mathieu N, Machiels JP, Kouri CE, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Culine S, Boher JM, Tergemina-Clain G, Legoupil C, Fizazi K.

Eur Urol. 2018 May;73(5):696-703. doi: 10.1016/j.eururo.2017.09.022. Epub 2017 Oct 23.

PMID:
29074061
20.

[Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].

Tostivint V, Racaud-Sultan C, Roumiguié M, Soulié M, Gamé X, Beauval JB.

Presse Med. 2017 Oct;46(10):954-965. doi: 10.1016/j.lpm.2017.06.014. Epub 2017 Sep 28. French.

PMID:
28967525

Supplemental Content

Loading ...
Support Center